FOLD logo

Amicus Therapeutics (FOLD) Net income

annual net income:

-$56.11M+$95.48M(+62.99%)
December 31, 2024

Summary

  • As of today (May 25, 2025), FOLD annual net profit is -$56.11 million, with the most recent change of +$95.48 million (+62.99%) on December 31, 2024.
  • During the last 3 years, FOLD annual net income has risen by +$194.35 million (+77.60%).
  • FOLD annual net income is now -754.36% below its all-time high of -$6.57 million, reached on December 31, 2009.

Performance

FOLD Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

quarterly net income:

-$21.69M-$36.42M(-247.13%)
March 31, 2025

Summary

  • As of today (May 25, 2025), FOLD quarterly net profit is -$21.69 million, with the most recent change of -$36.42 million (-247.13%) on March 31, 2025.
  • Over the past year, FOLD quarterly net income has increased by +$26.73 million (+55.21%).
  • FOLD quarterly net income is now -165.80% below its all-time high of $32.96 million, reached on December 31, 2009.

Performance

FOLD quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

TTM net income:

-$29.37M+$26.73M(+47.65%)
March 31, 2025

Summary

  • As of today (May 25, 2025), FOLD TTM net profit is -$29.37 million, with the most recent change of +$26.73 million (+47.65%) on March 31, 2025.
  • Over the past year, FOLD TTM net income has increased by +$117.70 million (+80.03%).
  • FOLD TTM net income is now -491.72% below its all-time high of -$4.96 million, reached on June 30, 2010.

Performance

FOLD TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

FOLD Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.0%+55.2%+80.0%
3 y3 years+77.6%+74.6%+89.1%
5 y5 years+84.3%+75.6%+91.0%

FOLD Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+77.6%-247.1%+74.6%at high+89.5%
5 y5-yearat high+84.3%-247.1%+75.6%at high+91.0%
alltimeall time-754.4%+84.3%-165.8%+86.4%-491.7%+93.4%

FOLD Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$21.69M(-247.1%)
-$29.37M(-47.6%)
Dec 2024
-$56.11M(-63.0%)
$14.74M(-319.0%)
-$56.11M(-46.4%)
Sep 2024
-
-$6.73M(-57.1%)
-$104.69M(-12.4%)
Jun 2024
-
-$15.70M(-67.6%)
-$119.54M(-18.7%)
Mar 2024
-
-$48.42M(+43.1%)
-$147.07M(-3.0%)
Dec 2023
-$151.58M(-35.9%)
-$33.84M(+56.8%)
-$151.58M(-12.7%)
Sep 2023
-
-$21.58M(-50.1%)
-$173.61M(-6.3%)
Jun 2023
-
-$43.23M(-18.3%)
-$185.31M(-9.3%)
Mar 2023
-
-$52.93M(-5.3%)
-$204.24M(-13.7%)
Dec 2022
-$236.57M(-5.5%)
-$55.87M(+67.8%)
-$236.57M(-10.4%)
Sep 2022
-
-$33.29M(-46.4%)
-$263.98M(-6.1%)
Jun 2022
-
-$62.16M(-27.1%)
-$280.99M(+4.0%)
Mar 2022
-
-$85.26M(+2.4%)
-$270.06M(+7.8%)
Dec 2021
-$250.46M(-9.5%)
-$83.28M(+65.6%)
-$250.46M(+5.0%)
Sep 2021
-
-$50.29M(-1.8%)
-$238.58M(-5.4%)
Jun 2021
-
-$51.23M(-22.0%)
-$252.30M(-0.5%)
Mar 2021
-
-$65.66M(-8.0%)
-$253.57M(-8.4%)
Dec 2020
-$276.85M(-22.3%)
-$71.40M(+11.5%)
-$276.85M(-6.2%)
Sep 2020
-
-$64.01M(+21.9%)
-$295.18M(+0.8%)
Jun 2020
-
-$52.49M(-41.0%)
-$292.98M(-9.9%)
Mar 2020
-
-$88.95M(-0.9%)
-$325.04M(-8.8%)
Dec 2019
-$356.39M(+2.1%)
-$89.73M(+45.2%)
-$356.39M(+3.4%)
Sep 2019
-
-$61.81M(-26.9%)
-$344.74M(-22.0%)
Jun 2019
-
-$84.55M(-29.7%)
-$442.09M(+5.4%)
Mar 2019
-
-$120.30M(+54.1%)
-$419.38M(+20.2%)
Dec 2018
-$349.00M(+22.9%)
-$78.08M(-50.9%)
-$348.99M(+2.6%)
Sep 2018
-
-$159.16M(+157.4%)
-$340.12M(+16.2%)
Jun 2018
-
-$61.83M(+23.9%)
-$292.62M(+4.9%)
Mar 2018
-
-$49.92M(-27.9%)
-$278.93M(-1.8%)
Dec 2017
-$284.00M(+42.0%)
-$69.21M(-38.0%)
-$284.00M(+3.9%)
Sep 2017
-
-$111.67M(+132.0%)
-$273.44M(+31.2%)
Jun 2017
-
-$48.14M(-12.5%)
-$208.43M(-1.4%)
Mar 2017
-
-$54.99M(-6.2%)
-$211.34M(+5.6%)
Dec 2016
-$200.04M(+51.4%)
-$58.65M(+25.7%)
-$200.04M(+8.5%)
Sep 2016
-
-$46.65M(-8.6%)
-$184.29M(+5.0%)
Jun 2016
-
-$51.05M(+16.8%)
-$175.44M(+15.8%)
Mar 2016
-
-$43.69M(+1.9%)
-$151.52M(+14.7%)
Dec 2015
-$132.12M(+91.7%)
-$42.90M(+13.5%)
-$132.12M(+19.6%)
Sep 2015
-
-$37.80M(+39.3%)
-$110.44M(+23.0%)
Jun 2015
-
-$27.13M(+11.7%)
-$89.79M(+16.2%)
Mar 2015
-
-$24.29M(+14.5%)
-$77.27M(+12.1%)
DateAnnualQuarterlyTTM
Dec 2014
-$68.93M(+15.6%)
-$21.22M(+23.7%)
-$68.93M(+15.0%)
Sep 2014
-
-$17.15M(+17.3%)
-$59.94M(+4.5%)
Jun 2014
-
-$14.61M(-8.3%)
-$57.38M(-1.3%)
Mar 2014
-
-$15.94M(+30.3%)
-$58.12M(-2.5%)
Dec 2013
-$59.63M(+22.2%)
-$12.24M(-16.1%)
-$59.63M(+3.9%)
Sep 2013
-
-$14.59M(-5.0%)
-$57.41M(-2.9%)
Jun 2013
-
-$15.35M(-12.1%)
-$59.11M(+11.3%)
Mar 2013
-
-$17.46M(+74.3%)
-$53.11M(+8.9%)
Dec 2012
-$48.78M(+9.8%)
-$10.02M(-38.5%)
-$48.78M(+2.9%)
Sep 2012
-
-$16.29M(+74.4%)
-$47.43M(+16.0%)
Jun 2012
-
-$9.34M(-28.9%)
-$40.90M(-7.5%)
Mar 2012
-
-$13.14M(+51.7%)
-$44.20M(-0.5%)
Dec 2011
-$44.41M(-19.2%)
-$8.66M(-11.2%)
-$44.41M(-12.6%)
Sep 2011
-
-$9.76M(-22.8%)
-$50.84M(-9.9%)
Jun 2011
-
-$12.64M(-5.3%)
-$56.44M(+2.4%)
Mar 2011
-
-$13.35M(-11.5%)
-$55.11M(+0.3%)
Dec 2010
-$54.94M(+736.5%)
-$15.09M(-1.8%)
-$54.94M(+697.1%)
Sep 2010
-
-$15.36M(+35.7%)
-$6.89M(+38.8%)
Jun 2010
-
-$11.31M(-14.1%)
-$4.96M(-31.7%)
Mar 2010
-
-$13.18M(-140.0%)
-$7.27M(+10.7%)
Dec 2009
-$6.57M(-83.3%)
$32.96M(-345.4%)
-$6.57M(-87.8%)
Sep 2009
-
-$13.43M(-1.4%)
-$53.67M(+10.8%)
Jun 2009
-
-$13.62M(+9.2%)
-$48.42M(+9.8%)
Mar 2009
-
-$12.47M(-11.9%)
-$44.10M(+12.0%)
Dec 2008
-$39.35M(-4.4%)
-$14.15M(+73.0%)
-$39.35M(+6.4%)
Sep 2008
-
-$8.18M(-12.0%)
-$36.98M(-5.4%)
Jun 2008
-
-$9.29M(+20.2%)
-$39.10M(-0.3%)
Mar 2008
-
-$7.73M(-34.3%)
-$39.20M(-4.8%)
Dec 2007
-$41.17M(-11.2%)
-$11.77M(+14.3%)
-$41.17M(+0.5%)
Sep 2007
-
-$10.30M(+9.7%)
-$40.98M(-3.0%)
Jun 2007
-
-$9.40M(-3.1%)
-$42.26M(-4.9%)
Mar 2007
-
-$9.70M(-16.3%)
-$44.45M(-4.1%)
Dec 2006
-$46.34M(+132.0%)
-$11.59M(+0.0%)
-$46.34M(+16.6%)
Sep 2006
-
-$11.59M(0.0%)
-$39.75M(+19.9%)
Jun 2006
-
-$11.59M(0.0%)
-$33.16M(+24.8%)
Mar 2006
-
-$11.59M(+132.0%)
-$26.57M(+33.0%)
Dec 2005
-$19.97M(+126.8%)
-$4.99M(0.0%)
-$19.97M(+33.3%)
Sep 2005
-
-$4.99M(0.0%)
-$14.98M(+50.0%)
Jun 2005
-
-$4.99M(0.0%)
-$9.99M(+100.0%)
Mar 2005
-
-$4.99M
-$4.99M
Dec 2004
-$8.81M(+30.1%)
-
-
Dec 2003
-$6.77M
-
-

FAQ

  • What is Amicus Therapeutics annual net profit?
  • What is the all time high annual net income for Amicus Therapeutics?
  • What is Amicus Therapeutics annual net income year-on-year change?
  • What is Amicus Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly net income year-on-year change?
  • What is Amicus Therapeutics TTM net profit?
  • What is the all time high TTM net income for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM net income year-on-year change?

What is Amicus Therapeutics annual net profit?

The current annual net income of FOLD is -$56.11M

What is the all time high annual net income for Amicus Therapeutics?

Amicus Therapeutics all-time high annual net profit is -$6.57M

What is Amicus Therapeutics annual net income year-on-year change?

Over the past year, FOLD annual net profit has changed by +$95.48M (+62.99%)

What is Amicus Therapeutics quarterly net profit?

The current quarterly net income of FOLD is -$21.69M

What is the all time high quarterly net income for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly net profit is $32.96M

What is Amicus Therapeutics quarterly net income year-on-year change?

Over the past year, FOLD quarterly net profit has changed by +$26.73M (+55.21%)

What is Amicus Therapeutics TTM net profit?

The current TTM net income of FOLD is -$29.37M

What is the all time high TTM net income for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM net profit is -$4.96M

What is Amicus Therapeutics TTM net income year-on-year change?

Over the past year, FOLD TTM net profit has changed by +$117.70M (+80.03%)
On this page